Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cavalli

Showing results (191-200 of 350) with videos related to

Pageof 35
Sort By:
American Journal of Clinical Oncology|October 1, 1982
An evaluation of tamoxifen dose escalation in advanced breast cancerA Goldhirsch, R A Joss, U Leuenberger, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1987
Phase II trial of triglycidylurazol (TGU) in advanced malignant melanomaS Gundersen, R Abele, F Cavalli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
A limited sampling model for the pharmacokinetics of etoposide given orallyD Gentili, M Zucchetti, V Torri, et al.
Leukemia & Lymphoma|August 23, 2000
Extranodal marginal zone B-cell lymphoma genotyping by Alu-polymerase chain reactionF Bertoni, R Müllenbach, M Broggini, et al.
International Journal of Cancer|April 13, 2000
Analysis of Fas/CD95 gene somatic mutations in ovarian cancer cell linesF Bertoni, A Conconi, S Carobbio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
START: a European state-of-the-art on-line instrument for clinical oncologistsP Casali, L Licitra, C Tondini, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials GroupS Gundersen, P Dombernowsky, F Cavalli, et al.
Schweizerische Medizinische Wochenschrift|December 31, 1977
[Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)]F Cavalli, L Tschopp, A Gerber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Proposing phase I studies: patients', relatives', nurses' and specialists' perceptionsM Tomamichel, H Jaime, A Degrate, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 1981
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses]A Goldhirsch, R Joss, F Cavalli, et al.
Pageof 35

Showing results (191-200 of 350) with videos related to

Sort By:
Pageof 35
American Journal of Clinical Oncology|October 1, 1982
An evaluation of tamoxifen dose escalation in advanced breast cancerA Goldhirsch, R A Joss, U Leuenberger, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1987
Phase II trial of triglycidylurazol (TGU) in advanced malignant melanomaS Gundersen, R Abele, F Cavalli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
A limited sampling model for the pharmacokinetics of etoposide given orallyD Gentili, M Zucchetti, V Torri, et al.
Leukemia & Lymphoma|August 23, 2000
Extranodal marginal zone B-cell lymphoma genotyping by Alu-polymerase chain reactionF Bertoni, R Müllenbach, M Broggini, et al.
International Journal of Cancer|April 13, 2000
Analysis of Fas/CD95 gene somatic mutations in ovarian cancer cell linesF Bertoni, A Conconi, S Carobbio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
START: a European state-of-the-art on-line instrument for clinical oncologistsP Casali, L Licitra, C Tondini, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials GroupS Gundersen, P Dombernowsky, F Cavalli, et al.
Schweizerische Medizinische Wochenschrift|December 31, 1977
[Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)]F Cavalli, L Tschopp, A Gerber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Proposing phase I studies: patients', relatives', nurses' and specialists' perceptionsM Tomamichel, H Jaime, A Degrate, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 1981
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses]A Goldhirsch, R Joss, F Cavalli, et al.
Pageof 35